Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-Independent Prostatic Cancer”

156 trials

Showing 20 of 156 results

Testing effectiveness (Phase 2)Study completedNCT00064610
What this trial is testing

Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 102
Not applicableWithdrawnNCT00559481
What this trial is testing

Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT01378091
What this trial is testing

Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 64
Testing effectiveness (Phase 2)Ended earlyNCT00459810
What this trial is testing

Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT00414388
What this trial is testing

Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 22
Large-scale testing (Phase 3)Active Not RecruitingNCT03748641
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic Cancer
Janssen Research & Development, LLC 765
Large-scale testing (Phase 3)Study completedNCT00286091
What this trial is testing

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Amgen 1,435
Testing effectiveness (Phase 2)Study completedNCT00005857
What this trial is testing

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00025194
What this trial is testing

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT04104607
What this trial is testing

The Bispecific PSMAxCD3 Antibody CC-1 in Patients with Castration Resistant Prostate Carcinoma

Who this might be right for
Castration-Resistant Prostatic Cancer
University Hospital Tuebingen 86
Testing effectiveness (Phase 2)Study completedNCT00939510
What this trial is testing

Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Robert Dreicer MD 32
Early research (Phase 1)Study completedNCT00052000
What this trial is testing

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT00861471
What this trial is testing

Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 24
Testing effectiveness (Phase 2)Study completedNCT00136526
What this trial is testing

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT00849290
What this trial is testing

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Who this might be right for
Metastatic Androgen Independent Prostate Cancer
Dendreon 113
Testing effectiveness (Phase 2)Study completedNCT00068731
What this trial is testing

Lycopene in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 47
Early research (Phase 1)Study completedNCT00006380
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00599313
What this trial is testing

Phase II Sunitinib Prog Met AIPC

Who this might be right for
Metastatic Prostate Cancer
US Oncology Research 36
Testing effectiveness (Phase 2)Study completedNCT00814788
What this trial is testing

Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, Davis 24
Early research (Phase 1)Looking for participantsNCT05997615
What this trial is testing

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
Vir Biotechnology, Inc. 390
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation